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Alterations in TI of Normal and Reperfused Infarcted 
Myocardium after Gd-BOPTA versus GD-DTPA on 
Inversion Recovery EPI 
Michael F. Wendland, Maythem Saeed, Kirsi Lauerma, Nikita Derugin, 
Jan Mintorovitch, Friedrich M. Cavagna, Charles B. Higgins 
This study tested whether Gd-BOPTA/Dimeg or Gd-DTPA ex- 
erts greater relaxation enhancement for blood and reperfused 
infarcted myocardium. Relaxivity of Gd-BOPTA is increased 
by weak binding to serum albumin. Thirty-six rats were sub- 
jected to reperfused infarction before contrast (doses = 0.05, 
0.1, and 0.2 mmollkg). AR1 was repeatedly measured over 30 
min. Gd-BOPTA caused greater AR1 for blood and myocar- 
dium than did Gd-DTPA; clearance of both agents from nor- 
mal and infarcted myocardium was similar to blood clearance; 
plots of ARlmyocardium/ARl blood showed equilibrium 
phase contrast distribution. Fractional contrast agent distri- 
bution volumes were approximately 0.24 for both agents in 
normal myocardium, 0.98 and 1.6 for Gd-DTPA and Gd- 
BOPTA, respectively, in reperfused infarction. The high value 
for Gd-BOPTPA was ascribed to greater relaxivity in infarction 
versus blood. It was concluded that Gd-BOPTNDimeg causes 
a greater AR1 than Gd-DTPA in regions which contain serum 
albumin. 
Key words: reperfused myocardial infarction; echo planar MR 
imaging; MR contrast media; T, measurement. 
INTRODUCTION 
Compartmentalization of contrast media and the equili- 
bration over time between intravascular and extracellular 
spaces determine the efficacy of MR contrast media. The 
kinetics of redistribution of these compounds play a ma- 
jor role in predicting the degree of enhancement of a 
particular tissue region (1, 2). 
It has been reported that the longitudinal relaxivity ( r l )  
of Gd-BOPTA/Dimeg in blood plasma is increased over 
that in aqueous solution from 4.4 to 9.7 s-' mM-' (3).  
This increased relaxivity is much greater than observed 
for Gd-DTPA such that in plasma the r l  for Gd-BOPTA/ 
Dimeg is approximately twice that for Gd-DTPA. A weak 
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binding between serum albumin and Gd-BOPTA/Dimeg 
has been identified (4) as the cause of the elevated relax- 
ivity and the binding affinity has been estimated to be 15 
mM in aqueous solutions of serum albumin based on the 
change in r l  (3). This increase in relaxivity may be used 
to advantage in imaging tissue with a high blood content 
or pathologic lesions (i.e., tumors or infarcted tissue) 
which contain large quantities of interstitial albumin 
since these zones may exhibit increased enhancement 
after Gd-BOPTA/Dimeg administration versus that from 
other available contrast media. Some of the main char- 
acteristics of reperfused infarcted myocardium are an 
expanded extracellular volume compared with normal 
myocardium, increased interstitial serum albumin con- 
tent, increased interstitial fluid pressure, and the pres- 
ence of cells with damaged membranes. The major patho- 
physiological mechanisms responsible for the increase in 
interstitial fluid pressure are the accumulation of plasma 
proteins and impaired function of the lymphatic system. 
Accordingly, the following study was conducted to 
quantify changes in R1 of blood, normal myocardium 
and reperfused infarcted myocardium after administra- 
tion Gd-BOPTAIDimeg and to compare with results ob- 
tained after administering the same doses of Gd-DTPA. In 
reperfused myocardial infarction, it is known that car- 
diac vasculature becomes very leaky to plasma proteins 
(5) and serum albumin accumulates in the myocardial 
interstitium of the injury zone. 
MATERIALS AND METHODS 
Contrast Media 
Gd-DTPA (gadopentetate dimeglumine, Magnevist; 
Schering AG, Berlin, Germany) was obtained as the clin- 
ical formulation containing 0.5 M Gd-DTPA. The prepa- 
ration, properties, and pharmacokinetics (6) of this agent 
have been previously described. Briefly, the compound 
has a low molecular weight (938 daltons, including 
dimeglumine) and extracellular distribution in most tis- 
sues, including myocardium. This agent exhibits no 
known interactions with proteins, it distributes rapidly 
throughout the body with generally simple pharmacoki- 
netics (i.e., no remote tissue compartments with slow 
distribution). It is cleared rapidly from the blood with a 
plasma half life of approximately 20 min in rodents (6). 
Gd-DTPA does not bind either to cellular membranes or 
to any macromolecular plasma components (7). 
Gd-BOPTA/Dimeg (gadobenate dimeglumine; Bracco 
SPA, Milan, Italy) was obtained from Bracco SPA, Milan, 
Italy, in septum-sealed vials containing the compound at 
a 0.5 M concentration. The synthesis ( 8 ) ,  physicochemi- 
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cal (3). and pharmacokinetic (9) properties of this agent 
have been described previously. Gd-BOPTAIDimeg has a 
similar molecular weight to Gd-DTPA (1060 daltons in- 
cluding dimeglumine) and distributes rapidly to extra- 
cellular compartments in most tissues. Its plasma clear- 
ance in rats has been characterized as biexponential with 
characteristic a and /3 coefficients of 5 and 22 min. Ap- 
proximately 52% of an intravenously injected dose is 
cleared via the biliary system in rats (3). 
The reported relaxivities for Gd-BOPTA/Dimeg at 20 
MHz in 0.15 MNaCl solution are 4.4 mM-' s-' for r l  and 
5.6 mM-' s-' for r2, similar to values for Gd-DTPA (3.7 
and 5.6 mM-' s - ' ,  respectively for r l  and r2). However, 
in heparinized human plasma r l  and r2 for Gd-BOPTA/ 
Dimeg are greatly increased, to 9.7 and 12.5 mM-' s-' 
(3); while r l  Gd-DTPA is only moderately increased, to 
4.9 m W '  s-'. The higher relaxivity of Gd-BOPTA/ 
Dimeg over Gd-DTPA is due to weak binding between the 
Gd-BOPTA/Dimeg and plasma proteins (3, 4). 
Animal Preparation 
Sprague-Dawley rats (n = 36) were anesthetized (50 
mg/kg sodium pentobarbital), and mechanically venti- 
lated after tracheotomy. A femoral vein was catheterized 
for delivery of contrast media. The chest was opened at 
the 4th intercostal space and a snare ligature was placed 
around the anterior branch of the left main coronary 
artery. The ligature was tightened to effect occlusion of 
the artery. In this preparation, the coronary artery is 
embedded within the myocardium and is not visible (10). 
The ligature encloses a small portion of myocardium 
which surrounds the vessel; therefore, successful occlu- 
sion is inferred by observing a zone of cyanosis along the 
anterior wall of the left ventricle distal to the occlusion 
site. Occlusion was maintained for 60 min before the 
ligature was loosened and removed to effect reperfusion. 
Successful reperfusion was verified by observing return 
of blood flow to the cyanotic zone. Reperfusion was 
maintained for 1 to 2 h before administration of contrast 
agent. This duration of occlusion and reperfusion was 
designed to produce a severe myocardial infarction (1 1, 
12)  with sufficient reperfusion duration to allow accu- 
mulation of serum proteins in the interstitium of the 
reperfused infarcted territory. 
Magnetic Resonance Imaging 
Copper leads were inserted into a forelimb and the lower 
abdomen and connected to an ECG monitor to provide 
cardiac gating. Each rat was placed supine in a birdcage 
resonator (5.6 cm diameter) and the heart was centered in 
the magnet (Bruker Omega 2.0 T system equipped with 
Accustar shielded gradients; Bruker Instruments, Inc., 
Fremont, CA). Magnetic field was optimized by shim- 
ming on the image section. 
ECG-gated axial inversion recovery echo planar imag- 
ing was employed to measure T,  values of LV chamber 
blood, normal myocardium and reperfused infarcted 
myocardium. A blipped EPI sequence was used with the 
following acquisition parameters: TR 2 7.0 s ,  TE = 10 
ms, matrix = 64 x 64 data points acquired in 32.7 ms, 
slice thickness = 2 mm, and FOV = 50 X 50 mm. Pre- 
paratory nonselective spin inversion was accomplished 
by a composite (9Ox-18Oy-90x1 radiofrequency pulse fol- 
lowed by gradient spoiling of residual transverse magne- 
tization. Before EPI, the inversion pulse was carefully 
calibrated for the slice location by maximizing the spin 
echo amplitude after a slice-selective pulse in a conven- 
tional hard inversion spin echo sequence. T ,  values were 
derived from measurement of the inversion recovery null 
point (TInull) by using the equation TI = TI,,,,,/ln 2. The 
null point was determined from a set of fully relaxed 
images in which the TI setting was incremented through 
a range of values such that at least three negative and 
three positive image intensities (SI I 35% of fully re- 
laxed intensity) were recorded for each region of interest. 
A delay following the ECG-derived R-wave trigger pulse 
was used to compensate changes in the TI setting such 
that all images were obtained at the same phase of the 
cardiac cycle. This set of images was typically acquired 
within a time interval of less than 3 min. 
Experimental Protocol 
Rats were divided into six groups (n = 6 per group). Each 
group was administered either Gd-DTPA or Gd-BOPTA/ 
Dimeg at doses of 0.05,O.l. or 0.2 mmol/kg. In each case 
the injected volume was 1.0 ml/kg. TI values were mea- 
sured before administering the contrast agent and at 4 ,9 ,  
14,19, 24 and 29 min afterward. These values refer to the 
time elapsed at the middle of each set of inversion recov- 
ery images. After imaging was complete, the rats were 
sacrificed by lethal injection of saturated potassium chlo- 
ride solution, the hearts removed, sectioned (short axis 
sections) and stained in triphenyltetrazolium chloride 
(TTC) to define the infarcted region. TTC staining was 
used only to confirm the presence and approximate lo- 
cation of myocardial infarction. 
Data Analysis 
Reconstructed images were identically scaled and con- 
verted from a 32-bit float to an 8-bit integer format and 
transferred to a Macintosh I1 computer. Images were in- 
terpolated to 128 x 1 2 8  and region-of-interest (ROI) anal- 
ysis was performed by using an image analysis program 
(Image, Wayne Rasband, NIH). Intensity measurements 
were obtained from myocardium (infarcted and unin- 
farcted regions) and LV chamber blood. The background 
noise level was typically between 5 and 10 units with 
maximal image intensities of 220-250 intensity units. 
Statistics 
All values are expressed as mean -C SEM The signifi- 
cance of differences between group mean values was 
determined by analysis of variance (ANOVA) and 
deemed to be significant with P < 0.05. Evaluation of the 
significance of changes over time of any measured quan- 
tity was evaluated by a one-way repeated measures 
ANOVA model, with subsequent multiple comparisons 
by using either Sheffe's F or Tukey's T test. In evaluating 
the effect of dose of a particular agent on measured val- 
ues, a multi-way repeated measures model was used 
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initially and further tests were performed only if differ- 
ences between groups were found to be significant. 
RESULTS 
Before administration of contrast media, apparent basal 
T,  values for regions of interest (LV chamber blood, 
infarcted and uninfarcted myocardium) were not differ- 
ent ( P  > 0.3) among the six groups of animals (Tables 1 
and 2) and were similar to published values (13, 14). 
Administration of all doses of each contrast media 
caused significant ( P  < 0.05) reduction in TI values of all 
three regions (Tables 1 and 2). In each case the relative 
magnitude of AR1 (l/T,post - 1/T,pre) for these regions 
followed the order: reperfused infarcted myocardium > 
LV blood > uninfarcted myocardium (Figs. 1-3). These 
differences were significant on individual 2-way re- 
peated measures ANOVA tests for each dose of both 
agents and allowed easy identification of the reperfused 
infarcted zone in each animal (Fig. I), which was similar 
in location and extent to the infarction zone observed on 
TTC stained sections. Increasing the dose of both agents 
caused significant increases in AR1 for all three regions 
(Figs. 2 and 3). 
In general, the AR1 value for each region was maximal 
at 4 min and thereafter decreased with time after admin- 
istration of contrast agent (Figs. 2 and 3). Consequently 
an apparent clearance half-time (i.e., half-time for AR1 
decrease) for each region could be estimated. For this 
estimation AR1 values in the time course were normal- 
ized to the initial value at 4 min postinjection and the 
Table 1 
T, Values (s) Measured after Administration of Gd-DTPA (n = 6) 
Region 
Normal mvo lnfarcted mvo 
Time Dose LVb,ood 
(min) (mmol/kg) 
0.05 
Pre 1.36 f 0.03 0.95 -t 0.02 1.14 2 0.02 
4 0.70 + 0.04 0.74 2 0.02 0.54 5 0.04 
9 0.80 ? 0.04 0.80 2 0.02 0.60 t 0.04 
14 0.86 ? 0.05 0.83 2 0.02 0.65 5 0.03 
19 0.91 f 0.05 0.84 % 0.02 0.68 5 0.02 
24 0.95 t 0.05 0.85 -t 0.02 0.72 5 0.02 
29 0.98 t 0.05 0.86 ? 0.02 0.73 5 0.02 
0.1 
Pre 1.35 f 0.03 0.97 t 0.01 1.18 2 0.03 
4 0.40 + 0.04 0.58 -t 0.03 0.28 t 0.03 
9 0.46 -t 0.05 0.62 _f 0.03 0.32 2 0.03 
14 0.52 f 0.06 0.64 t 0.04 0.36 5 0.04 
19 0.58 2 0.07 0.67 -t 0.04 0.40 2 0.05 
24 0.61 t 0.09 0.70 2 0.04 0.43 5 0.07 
29 0.63 z 0.09 0.71 t 0.05 0.45 2 0.07 
~~ 
0.2 
pre 1.32 t 0.03 0.94 2 0.01 1.1 6 2 0.02 
4 0.24 2 0.02 0.44 + 0.02 0.15 5 0.01 
9 0.31 2 0.02 0.50 2 0.02 0.19 2 0.01 
14 0.33 2 0.02 0.53 ? 0.01 0.21 2 0.01 
19 0.36 2 0.02 0.56 t 0.01 0.24 2 0.02 
24 0.38 t 0.02 0.58 t 0.02 0.26 5 0.02 
29 0.40 t 0.03 0.59 ? 0.02 0.27 5 0.02 
Table 2 
T, Values (s) Measured after Administration of Gd-BOPTNDimeg 
(n = 6) 
Region Time Dose Lv 
(min) (mrnol/kg) Normal mvo lnfarcted my0 
0.05 
Pre 1.29 -C_ 0.04 0.96 2 0.02 1.11 t 0.02 
4 0.50 -C 0.04 0.65 ? 0.03 0.32 L 0.03 
9 0.66 % 0.07 0.73 C 0.03 0.40 t 0.04 
14 0.76 2 0.07 0.77 ? 0.03 0.43 t 0.05 
19 0.81 2 0.08 0.78 2 0.03 0.48 2 0.05 
24 0.91 2 0.08 0.83 2 0.03 0.56 t 0.06 
29 0.94 2 0.10 0.85 t 0.03 0.60 2 0.07 
0.1 
Pre 
4 
9 
14 
19 
24 
29 
0.2 
Pre 
4 
9 
14 
19 
24 
29 
1.35 t 0.04 
0.34 ? 0.04 
0.48 t 0.06 
0.57 t 0.07 
0.63 t 0.07 
0.69 ? 0.08 
0.73 ? 0.08 
1.29 t 0.03 
0.19 t 0.02 
0.29 2 0.06 
0.37 t 0.07 
0.42 t 0.08 
0.47 t 0.09 
0.51 2 0.09 
0.98 2 0.03 1.20 L 0.03 
0.53 2 0.05 0.20 I0 .04  
0.61 t 0.05 0.26 t 0.04 
0.66 t 0.05 0.31 5 0.04 
0.69 2 0.04 0.37 2 0.04 
0.72 2 0.04 0.40 t 0.04 
0.74 t 0.04 0.44 10.04 
0.92 f 0.02 1.14 -t 0.03 
0.42 t 0.03 0.12 -t 0.01 
0.51 -t 0.05 0.13 t 0.02 
0.56 t 0.05 0.16 5 0.03 
0.61 t 0.05 0.19 5 0.03 
0.62 t 0.05 0.22 2 0.04 
0.65 -t 0.06 0.25 ? 0.04 
resultant curves were fit to a double exponential func- 
tion. The fit curves (not shown) were used only to esti- 
mate the time at which the initial AR1 had declined by 
half. The apparent clearance of Gd-BOPTA/Dimeg from 
the blood was significantly faster than that of Gd-DTPA 
(Table 3). Clearance of neither agent was altered signifi- 
cantly by increasing the dose. The apparent clearance 
half-times for normal myocardium were similar to values 
for blood with the respective agent and was not altered 
by increasing the dose (Table 3). The apparent clearance 
of Gd-DTPA from reperfused infarcted myocardium was 
also similar to that from blood, indicating that contrast 
agent is not sequestered in the injury zone in this prep- 
aration. However, the clearance of Gd-BOPTA/Dimeg 
from reperfused infarction was slower than from either 
blood or myocardium (Table 3). 
The similarities in clearance are depicted in plots of 
ARlmyocardium/ARlblood (Fig. 4), which were constant 
over time for normal myocardium. Increasing the dose of 
Gd-DTPA had no effect on the value of this ratio; how- 
ever, with Gd-BOPTA/Dimeg the largest dose produced 
significantly smaller values for ARImyocardium/ 
ARlblood (0.32 5 0.02) than did the lower doses (0.44 2 
0.02, and 0.43 -t 0.03, respective time averaged values for 
doses of 0.1 and 0.05 mmollkg. P < 0.05). Analogous 
plots for reperfused infarction were also constant over 
time for animals that received Gd-DTPA and the value of 
ARlmyocardium/ARlblood did not change with dose 
(Fig. 4. bottom); however, the value for this ratio was 
much larger than that observed for normal myocardium. 
In animals that received Gd-BOPTA/Dimeg, the AR1 ratio 
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FIG. 1. R1 measurement in one animal. Images were obtained 24 min after administration of 0.1 mmol/kg Gd-BOPTNDimeg. TI settings 
for these images were: (a) 0.05, (b) 0.1 5, (c) 0.25, (d) 0.3, (e) 0.4, and (9 0.6 s. All images are displayed in magnitude intensity form, with 
all regions exhibiting negative intensity at TI = 0.05 s and positive intensity at TI = 0.6 s. Regions with larger R1 values demonstrate null 
intensity at smaller TI settings, thus  R1 of reperfused infarction (arrows) > R1 of chamber blood > R1 of normal myocardium. These 
images were all zoomed once to the region of the heart and then interpolated. Images thus depict raw data matrices of 32 x 32 points. 
Note that the reperfused infarction in (c) is surrounded by a null boundary (one pixel wide on uninterpolated images), which aids 
assignment of regional signal polarity when signal approaches the null point. 
for reperfused infarction exhibited an initial increase in 
value during the first 10 min after administration and 
thereafter did not change during the remaining observa- 
tion period (Fig. 4, top). This profile was the same for all 
doses of Gd-BOPTAIDimeg. The value of the AR1 ratio in 
the constant region of the curve was significantly greater 
than that for normal myocardium in animals that re- 
ceived Gd-BOPTA/Dimeg and was also significantly 
greater than values observed for reperfused infarction in 
animals that received Gd-DTPA (Fig. 4). Finally, AR1 of 
reperfused infarction relative to that of normal myocar- 
dium was significantly greater in animals that received 
Gd-BOPTA/Dimeg versus animals that received Gd- 
DTPA (Fig. 5), indicating that contrast between normal 
and reperfused infarcted myocardium would be greater 
by using Gd-BOPTA/Dimeg. 
The major limitation associated with this study is related 
to the method of TI measurement during the clearance 
phase of contrast media. In selecting a method for TI 
estimation it was considered important to determine T, 
from as few measurements as possible since the contrast 
agent concentration, and hence the TI values, were 
changing with time during clearance. It was also impor- 
tant to avoid error from T, decreases that accompany 
contrast media and confound TI calculation from signal 
intensity change in individual images. Consequently, the 
compromise solution used in the current study was to 
estimate the inversion recovery null point, which is in- 
sensitive to T, error and greatly reduces the temporal 
error caused by the effects of clearance on the inversion 
recovery profile. Temporal misregistration for zones with 
different T, values is still present because null intensity 
was not observed at the same time for each region. This 
error was not large because observation of null intensity 
for the region with smallest T,  (reperfused infarction) 
was always within 60 s of that for the region with greatest 
T, (usually normal myocardium). This temporal offset is 
small compared with the clearance time for agents used 
in this study, and error that propagates into AR1 ratio 
values is considered negligable. 
Reperfusion of infarcted myocardium initiates a pro- 
gression of changes in the myocardium both at the cel- 
lular and tissue levels that have a pronounced impact on 
the influence of exogenous MR contrast media on R1 of 
the damaged zone, and consequently on signal intensity 
of T,-weighted MR images. Early after reflow is estab- 
lished, irreversibly injured myocardium undergoes ex- 
plosive cellular swelling caused by re-establishment of 
normosmotic extracellular conditions while the intracel- 
lular fluid is hyperosmotic from ion imbalance during 
ischemia (15). Membrane damage from cellular swelling 
as well as potential enzymic activation of phospho- 
lipases during intracellular calcium overload and free 
radical damage during initial reperfusion causes a failure 
of membrane integrity. With the failure of membrane 
integrity, low molecular weight exogenous contrast me- 
dia are no longer excluded from the cellular spaces (16, 
17). The available distribution volume and hence the 
quantity of MR contrast medium per pixel are increased. 
Secondly, damage to the microvascular endothelium oc- 
curs leading initially to increased leakage of macromol- 
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FIG. 2. Change in AR1 of left ventricle chamber blood, infarcted 
myocardium and normal myocardium after administration of Gd- 
BOPTAfDimeg to six rats subjected to 60 min left coronary occlu- 
sion and reflow. Note that hR1 of reperfused infarcted myocar- 
dium is greater than that in blood and normal myocardium, and 
decreases with time for ail three regions. 
ecules into the interstitium of the injured territory (18). 
This combined with the liberation of intracellular pro- 
teins increases the osmolarity in the interstitium and 
consequently interstitial edema evolves. Interstitial 
edema also enlarges the distribution volume of contrast 
media. It is thought that progressive swelling of the tissue 
ultimately compresses the microvasculature to the extent 
that perfusion is eventually blocked at the microvascular 
level producing the "no-reflow" phenomenon (19, 20). 
On MR imaging reperfused myocardial infarction is 
typically characterized by intense postcontrast signal en- 
hancement on T,-weighted sequences (21-25). The en- 
hancement is usually very homogeneous and persists for 
more than 1 h after administering contrast media, and 
little notable decrease in signal enhancement is observed 
during this 1st h (22-25). To the contrary, normal myo- 
cardium exhibits a maximal enhancement early after ad- 
ministration followed by decreasing enhancement with 
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DTPA to six rats subjected to 60 min left coronary occlusion and 
reflow. Note that (a) similar to animals that received Gd-BOPTN 
Dimeg, reperfused infarcted myocardium demonstrated greatest 
r h n n n n  in R1 while +mailer channes  were evident for chamber 
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ilar declines in AR1 over time; and (c) hR1 values were generally 
less than in animals that were given Gd-BOPTNDimeg. 
- .  . ^ .  time after injection reflecting clearance of the agent trom 
the circulation (22-25). These temporal features have led 
to the hypothesis that the contrast agent is sequestered in 
the reperfused infarcted zone by a combination of en- 
larged distribution volume and poor perfusion in the 
damaged territory (21, 22, 24, 25). Indeed, in this model 
it has been shown that the first pass profile for T,-en- 
hancing MRI media is reduced compared with that of 
normal myocardium followed by continued slow in- 
crease in signal (26), supporting the hypothesis of dimin- 
ished flow and slow accumulation of agent in the injury 
zone. 
The results from the current study suggest that the 
former view is not entirely correct. While perfusion may 
be reduced in the reperfused infarcted territory, it is not 
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Table 3 
Clearance Half-Time Values (min) for Gd-DTPA and Gd-BOPTNDimeg 
normal myocardium 
 
I 
GdDTPA dose (mmollkg) 
+0.05 + O . l  *0.2 
na 
2 .0 -  
AR1 myo O S o =  
AR1 inf -
8 .0 -  
6 . 0 -  
LV blood 
-0.05 +0.10 -0.20 
I 
GdDTPA dose (mmol/kg) 
-0.05 *0.10 -0.20 
Normal myocardium Reperfused infarcted mvocardium 
Gd-DTPA 0.05 mmol/kg 5 1 8 + 3  
Gd-DTPA 0.1 mmol/kg 6 23 ? 4 
Gd-BOPTA 0.05 mmol/kg 5 10 + 2b 
Gd-BOPTA 0.1 mmol/kg 5 10 2b 
Gd-DTPA 0.2 mmol/kg 5 21 + 3  
Gd-BOPTA 0.2 mmol/kg 4 10 z 2b 
1 6 2 3  
1 3 2 3  
24 2 4 
13 t 2b 
23 2 2 
11 2 2 b  
21 ? 4  
18 -C 3" 
22 -c 4 
19 2 5" 
1 8 2 2  
19 -c 4= 
a n  was reduced from 6 as shown because in each group there was usually at least one case in which clearance from the blood was exceedingly slow (i.e., 
>35 min) and a clearance half-time could not be accurately measured. These cases were excluded from consideration of clearance but were included in all 
other evaluations; the apparent linearity of temporal values of ARlratio was not affected by the slow blood clearance (i.e.. clearance from myocardium was 
equally slow as that from blood). 
P < 0.05 in comparison with values obtained with Gd-DTPA on unpaired two-tailed Students t test. 
P < 0.05 in comparison with value obtained for blood on paired two-tailed Student's t test. 
sufficiently slow to kinetically sequester contrast agent 
in the reperfused infarcted territory from that in the 
central blood pool in this model. Apparent clearance 
from reperfused infarcted myocardium was largely un- 
impeded compared with clearance from central blood. 
This finding was unanticipated but is consistent if one 
considers that the only requirement for apparent unim- 
peded clearance is that contrast media in the reperfused 
infarction must mix with that in the central blood plasma 
more quickly than the agent is cleared from the plasma, 
and plasma clearance is a rather slow process. The pre- 
vious findings that signal enhancement of reperfused 
myocardium is nearly constant over 60 min after contrast 
3.0- 
2.0- infarcted myocardium 
1 . o  
2.0-1 - T I  
normal myocardium 
0.0 
0 5 1 0  1 5  2 0  2 5  3 0  
time (min) 
FIG. 4. Change in AR1 myocardium/ARl blood after administra- 
tion of Gd-BOPTNDimeg and Gd-DTPA. Notice that all regions 
demonstrate no dose dependence and either constant values for 
the AR1 ratio or initial rise to a constant value (reperfused infarc- 
tion in animals given Gd-BOPTNDimeg) suggesting equilibrium 
phase contrast distribution between myocardium and blood. 
administration can be explained if TI of the reperfused 
infarcted zone is sufficiently short that the region is 
nearly fully relaxed (i.e., TR 2 3 * T,) for all postcontrast 
images, such that real reduction of contrast agent over 
time is simply not observed. 
Evaluation of AR1 Myocardium/ARl blood Values 
The expression of the measured data as ARlmyocardiuml 
ARlblood and its temporal changes provides a highly in- 
formative perspective of contrast distribution in the myo- 
cardium and of the physiologic status of the tissue, 
particularly in regions of myocardial damage. In the ab- 
sence of accurate blood data, such as in a spin-echo 
10.0, 
4.0 GdBOPTA dose (mmol/kg) 
0.0 2-01 0 5 1 0  1 5  2 0  2 5  3 0  
time (min) 
FIG. 5. Change in AR1 infarcVAR1 normal myocardium after ad- 
ministration of Gd-BOPTNDimeg and Gd-DTPA. Notice that ani- 
mals that received Gd-BOPTNDimeg exhibit significantly larger 
values for this ratio than animals that received Gd-DTPA, indicat- 
ing that Gd-BOPTNDimeg would provide greater contrast be- 
tween normal and reperfused infarcted regions on T,-weighted 
MRI. 
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acquisition, comparison of AR1 ratios at different myocar- 
dial regions also provides a useful index. 
To evaluate the ARI ratio plots, we use an approximate 
pharmacokinetic description of contrast agent distribu- 
tion in perfused myocardium that is appropriate to the 
experimentally measured quantities: 
where CM is contrast media, “myo” and “pl” refer to 
myocardium and blood plasma, respectively, kinnux and 
kern,,, refer to rate constants for influx of contrast media 
from blood to myocardium and efflux from myocardium 
to blood, and k, refers to the plasma clearance rate con- 
stant. In this model, all of the rate constants “k” are 
summary constants in that none represents a single pro- 
cess. kinflux and kefflux contain contributions from (a) the 
exchange of blood between the local tissue blood com- 
partment and the central c:irculation (perfusion); (b) the 
traversal of CM across the capillary wall (i.e., permeabil- 
ity surface area product); and (c) the mixing of CM within 
the interstitium (diffusion). In normal myocardium it is 
assumed that blood flow and intracompartment mixing 
do not appreciably limit influx and efflux of extravascu- 
lar contrast media but in injured myocardium the valid- 
ity of these assumptions is doubtful and supportive ex- 
perimental evidence is required. k, characterizes the 
combined processes of endpoint clearance via biliary and 
renal systems and exchange into remote tissue (muscle, 
gut, and other organs) compartments which buffers the 
central plasma concentration during clearance. It is as- 
sumed that myocardial interstitium is very small com- 
pared with the remaining whole body distribution vol- 
ume for contrast agent and therefore back diffusion of CM 
from myocardium to blood contributes negligibly to the 
central plasma concentration. 
The change in R? of myocardium and blood can be 
approximately related to change in contrast media con- 
centration as: 
= [CMIpl X (1.0 - Hct) X rlblood 
where fECV refers to the fractional extracellular volume, 
Hct is the blood hematocrit, and rlmyo and rlblood refer 
respectively to local longitudinal relaxivities for contrast 
medium in myocardium and blood. These expressions as- 
sume that intercompartment mixing of tissue water is very 
rapid, and current evidence indicates this is not true for 
mixing between intravascular and extravascular water com- 
partments within myocardium (14, 27-29). However, with 
contrast media present in both vascular and extravascular 
compartments, relaxation rates would be similar and slow 
water exchange would not appreciably limit the overall rate 
(30). Then, dividing Eq. 121 by Eq. 13) (31): 
where the AR1 ratio is expressed as the product of the 
ratios of (a) concentration of agent in the myocardium to 
that in blood distribution volumes, (b) the fractional dis- 
tribution volumes in myocardium to whole blood, and (c) 
the respective local longitudinal relaxivities of contrast 
agent in the two compartments. Any possible limiting 
effect of water exchange between intracellular and extra- 
cellular compartments on relaxation is included in the 
local relaxivities. This is appropriate because any depar- 
ture from monoexponential relaxation would not be ob- 
servable in this measurement since [a) complete relax- 
ation profiles were not obtained, (b) signal-to-noise ratio 
was sufficient to detect only great departure from mono- 
exponential behavior (32), and (c) R1  was changing with 
time while measurements were being recorded. 
After contrast media is administered, its concentration 
in the plasma initially exceeds that in the myocardial 
interstitium. Since [CMIpl X kin > [CM],,, x kout, there 
is a net increase of [CMImyo with time until the condi- 
tion is reached that [CMlpl x kin = [CMImyo x kout. 
This initial process can be considered the tissue loading 
phase and in normal myocardium this process is com- 
plete within the first minutes after contrast administra- 
tion. Subsequent clearance of CM from the plasma causes 
net clearance of CM from the tissue. If kin kout >> kc, 
then clearance of CM from the myocardium will very 
nearly keep pace with plasma clearance and [CMIEcv/ 
(CM]pl = kin/kout. Alternatively, if  kin=kout=kc, clear- 
ance of CM from tissue will lag that from plasma and 
[CMIECv/[CM]pl will increase with time until [CMIpl 
approaches zero (14). The former circumstance is more 
consistent with the results of the current study. Finally, 
since movement of CM between blood and tissue com- 
partments is passive rather than facilitated, it is assumed 
that kin = kout. Eq. 141 can be simplified and rearranged 
to: 
ARlrnyo/ARlblood x (1.0 - Hct) = fECV X rlmyo/rlblwd 
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It is noteworthy that (a) fECV includes the myocardial 
blood plasma volume within each pixel and that the 
distribution volume is not a true volume but is taken to 
be the fraction of total MR observable water within each 
pixel that is contained in the space available for contrast 
media distribution; and (b) this expression is applicable 
only if [CM],,,/[CM]pl is equal to 1,  a condition that is 
supported by ARlmyo/ARlblood being constant over 
some interval of time and insensitive to administered 
dose. 
In normal (uninfarcted) myocardium, the ARlmyo/ 
ARlblood ratio observed after Gd-DTPA was approxi- 
mately 0.4, regardless of the injected dose and time after 
administration. Assuming Hct to be approximately 0.4, 
the product of ARlrnyo/ARlblood and (1 - Hct), is ap- 
proximately 0.24. This value is less than expected for 
normal myocardium. The fractional distribution volume 
T of Infarcted Myocardium after Gd-Based Contrast Media 455 
in myocardium of '53Gd-DTPA or tracers with similar 
molecular weight is typically between 0.3 and 0.4 (33, 
34). The expected AR1 ratio would be 0.5 to 0.7 rather 
than 0.4 if the ratio of local relaxivities, rlmyo/rlblood, 
is unity. The true cause of this discrepancy is unknown, 
but possible explanations might be that (a) values ob- 
tained from sacrificed animals, as in radioisotope exper- 
iments, may be higher than in living animals since the 
myocardial blood volume can increase appreciably de- 
pending upon the manner of sacrifice; and (b) the A R 1  
method may give an erroneously low value because r l  
myo is limited by water exchange between intracellular 
and extracellular spaces. While it is true that departure 
from monoexponential relaxation is not usually apparent 
after quite high doses of Gd-DTPA, the local r l  would be 
reduced appreciably before compartmentalization is ev- 
ident as biexponential relaxation. 
In reperfused infarction the AR1 ratio value was con- 
stant with time after administration of Gd-DTPA and was 
independent of dose, therefore it is likely that kin, kout 
>> kc. If the r l  ratio is unity, then the apparent fECV is 
0.6 x 1.63 0.98, indicating that virtually all of the 
myocardial cellular volume in the injury zone is within 
the distribution volume of the contrast agent, probably 
indicating lethal cell membrane damage. This finding is 
important because it suggests a method for quantifying 
the necrotic cell fraction within the infarcted territory 
which may be less than 100% (12) in less severe injury. 
The results obtained with Gd-BOPTA/Dimeg are more 
difficult to rationalize. It was true that generally greater 
AR1 values were noted in the blood pool after adminis- 
tering Gd-BOPTA/Dimeg as compared with Gd-DTPA 
(2.46 2 0.4 versus 1.88 ? 0.2), in accord with the known 
effect of serum albumin on r l  in blood, but increases 
were also noted in AR1 values of myocardium (0.96 2 0.2 
versus 0.72 c 0.1). Thus, a significant difference between 
AR1 ratio values was not obtained. However, one would 
expect that AR1 of myocardium would be dominated by 
Gd-BOPTA/Dimeg in the interstitium rather than by that 
in the myocardial blood because (a) the interstitial vol- 
ume is larger than the blood volume and (b) limited 
transcapillary exchange of water would reduce the access 
of most of the tissue water, that in the cellular spaces, to 
the intravascular compartment. Since there is very little 
albumin present in interstitium of normal myocardium, 
rlblood is expected to be greater than r l  myocardium 
which in turn should cause lower ARlmyo/ARlblood 
values than obtained with Gd-DTPA. Why was this ex- 
pected lowering of the AR1 ratio only found at a dose of 
0.2 mmol/kg and not at the lower doses? We can only 
speculate that transcapillary exchange of water is suffi- 
ciently fast that at the lower doses the higher relaxation 
rate in the tissue blood penetrates into the extravascular 
Compartment. This is not a very satisfactory explanation 
because when the agent was cleared from the blood after 
the higher dose, the AR1 ratio did not increase toward the 
value observed at the lower doses. 
In reperfused infarcted myocardium, the AR1 ratio ex- 
hibited an initial rise to a constant high value suggesting 
an approach to equilibrium phase distribution. The AR1 
value in the constant portion was much higher than 
noted for Gd-DTPA. If we assume that equilibrium dis- 
tribution exists in this portion of the curve, then the 
fECV-r1 ratio product (i.e., right hand side of Eq. 151) is 
approximately 2.7 x 0.6 = 1.62. Obviously, the fECV 
cannot be greater than 1.0 forcing the rlmyo/rlblood 
ratio to at least a value of 1.6. This value for r1 ratio 
cannot be explained solely on the basis of serum albumin 
accumulation in the reperfused infarcted tissue. Albu- 
min concentration in the extravascular compartment 
cannot be higher than in plasma since plasma is its only 
source. Thus, the ratio of relaxivities of Gd-BOPTA/ 
Dimeg in tissue to that in blood should not exceed unity 
unless there is a change in bound-site relaxation rate 
(meaning relaxation rate of water ligated to gadolinium) 
or a change in fraction of Gd-BOPTA/Dimeg that is 
bound to protein. Since myocardial intracellular proteins 
are available for interaction with Gd-BOPTA in the dam- 
aged territory, it seems most sensible to ascribe the ap- 
parent elevation of Gd-BOPTAIDimeg relaxivity in the 
tissue to an increased fraction of bound Gd-BOPTA/ 
Dimeg in this region. 
CONCLUSIONS 
The important findings of this study were that (a) when 
administered at similar dose levels, Gd-BOPTA/Dimeg 
causes greater increases in R 1  than provided by Gd- 
DTPA consistent with its known larger r l  relaxivity of 
the former agent in solutions containing serum albumin. 
This effect is particularly important in reperfused in- 
farcted myocardium where plasma proteins are known to 
accumulate and greater potential contrast between reper- 
fused infarction and normal myocardium would be avail- 
able for ?",-weighted imaging; (b) AR1 values were great- 
est in reperfused infarcted myocardium, less in chamber 
blood, and least in normal myocardium throughout the 
observation, and the agent was cleared efficiently from 
all myocardial regions indicating that the contrast agent 
is not sequestered in reperfused myocardial infarction for 
this preparation; (c) the ratio of AR1 values in tissue to 
that in blood were consistent with a Gd-DTPA distribu- 
tion volume containing 24% of myocardial water (in- 
cluding myocardial blood volume) in normal or unin- 
jured myocardium and nearly 100% in hearts subjected 
to reperfused infarction. This finding suggests that the 
ARl ratio can be used to quantify the fraction of viable 
myocardial cells present in reperfused infarcted territo- 
ries containing a mixture of viable and nonviable cells. 
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